Pretreatment Tumor NECTIN4 RNA Expression Is Associated with First-line Enfortumab Vedotin Plus Pembrolizumab Efficacy in Metastatic Urothelial Cancer.
- DOI
- 10.1016/j.eururo.2026.08.005
- Published
- 2026 Sep 24
- Container
- European urology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.eururo.2026.08.005,
title = {Pretreatment Tumor NECTIN4 RNA Expression Is Associated with First-line Enfortumab Vedotin Plus Pembrolizumab Efficacy in Metastatic Urothelial Cancer.},
author = {Cho BA and Perry CJ and Yoo SK and Mercer J and Thai C and Sonpavde G and Fields PA and Tan A and Petrylak DP and Galsky MD},
year = {2026},
journal = {European urology},
doi = {10.1016/j.eururo.2026.08.005},
url = {https://doi.org/10.1016/j.eururo.2026.08.005}
}RIS
TY - JOUR TI - Pretreatment Tumor NECTIN4 RNA Expression Is Associated with First-line Enfortumab Vedotin Plus Pembrolizumab Efficacy in Metastatic Urothelial Cancer. AU - Cho BA AU - Perry CJ AU - Yoo SK AU - Mercer J AU - Thai C AU - Sonpavde G AU - Fields PA AU - Tan A AU - Petrylak DP AU - Galsky MD PY - 2026 JO - European urology DO - 10.1016/j.eururo.2026.08.005 UR - https://doi.org/10.1016/j.eururo.2026.08.005 ER -
APA
BA, C., CJ, P., SK, Y., J, M., C, T., G, S., PA, F., A, T., DP, P., & MD, G. (2026). Pretreatment Tumor NECTIN4 RNA Expression Is Associated with First-line Enfortumab Vedotin Plus Pembrolizumab Efficacy in Metastatic Urothelial Cancer.. European urology. https://doi.org/10.1016/j.eururo.2026.08.005
Source records
- pubmed · retrieved 2026-09-27T10:28:20.531Z